Stock price
Market cap
At each fiscal year end, then the latest quarter end: closing price × shares outstanding.
Show tableHide table
| Period | Market cap |
|---|---|
| FY2016, ended Dec 31, 2016 | $56.8B |
| FY2017, ended Dec 31, 2017 | $55.0B |
| FY2018, ended Dec 31, 2018 | $51.9B |
| FY2019, ended Dec 31, 2019 | $45.7B |
| FY2020, ended Dec 31, 2020 | $28.0B |
| FY2021, ended Dec 31, 2021 | $52.5B |
| FY2022, ended Dec 31, 2022 | $38.4B |
| FY2023, ended Dec 31, 2023 | $46.5B |
| FY2024, ended Dec 31, 2024 | $56.2B |
| FY2025, ended Dec 31, 2025 | $60.2B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $72.4B |
Revenue
By fiscal year, then the trailing 12 months
Show tableHide table
| Period | Revenue |
|---|---|
| FY2016, ended Dec 31, 2016 | $5.44B |
| FY2017, ended Dec 31, 2017 | $5.53B |
| FY2018, ended Dec 31, 2018 | $5.65B |
| FY2019, ended Dec 31, 2019 | $5.76B |
| FY2020, ended Dec 31, 2020 | $4.61B |
| FY2021, ended Dec 31, 2021 | $5.12B |
| FY2022, ended Dec 31, 2022 | $5.29B |
| FY2023, ended Dec 31, 2023 | $5.66B |
| FY2024, ended Dec 31, 2024 | $5.96B |
| FY2025, ended Dec 31, 2025 | $6.36B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $6.94B |
Net income and free cash flow
By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.
Show tableHide table
| Period | Net income | Free cash flow |
|---|---|---|
| FY2016, ended Dec 31, 2016 | $1.84B | $2.57B |
| FY2017, ended Dec 31, 2017 | $1.94B | $2.86B |
| FY2018, ended Dec 31, 2018 | $2.44B | $2.97B |
| FY2019, ended Dec 31, 2019 | $2.10B | $2.93B |
| FY2020, ended Dec 31, 2020 | $1.11B | $1.84B |
| FY2021, ended Dec 31, 2021 | $2.25B | $3.11B |
| FY2022, ended Dec 31, 2022 | $2.14B | $3.12B |
| FY2023, ended Dec 31, 2023 | $2.28B | $3.14B |
| FY2024, ended Dec 31, 2024 | $2.37B | $3.06B |
| FY2025, ended Dec 31, 2025 | $4.62B | $3.20B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $4.62B | $3.22B |
Cash and cash equivalents
At each fiscal year end, then the latest quarter end.
Show tableHide table
| Period | Cash and cash equivalents |
|---|---|
| FY2016, ended Dec 31, 2016 | $560M |
| FY2017, ended Dec 31, 2017 | $1.48B |
| FY2018, ended Dec 31, 2018 | $514M |
| FY2019, ended Dec 31, 2019 | $669M |
| FY2020, ended Dec 31, 2020 | $1.01B |
| FY2021, ended Dec 31, 2021 | $534M |
| FY2022, ended Dec 31, 2022 | $622M |
| FY2023, ended Dec 31, 2023 | $1.17B |
| FY2024, ended Dec 31, 2024 | $1.40B |
| FY2025, ended Dec 31, 2025 | $823M |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $1.02B |
Total debt
At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.
Show tableHide table
| Period | Total debt |
|---|---|
| FY2016, ended Dec 31, 2016 | $23.0B |
| FY2017, ended Dec 31, 2017 | $24.6B |
| FY2018, ended Dec 31, 2018 | $23.3B |
| FY2019, ended Dec 31, 2019 | $24.2B |
| FY2020, ended Dec 31, 2020 | $26.7B |
| FY2021, ended Dec 31, 2021 | $25.3B |
| FY2022, ended Dec 31, 2022 | $25.0B |
| FY2023, ended Dec 31, 2023 | $26.0B |
| FY2024, ended Dec 31, 2024 | $24.3B |
| FY2025, ended Dec 31, 2025 | $28.4B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $28.7B |
Shares outstanding
At each fiscal year end, then the latest quarter end, adjusted for splits. Up 1.2% since FY16.
Show tableHide table
| Period | Shares outstanding |
|---|---|
| FY2016, ended Dec 31, 2016 | 320M |
| FY2017, ended Dec 31, 2017 | 320M |
| FY2018, ended Dec 31, 2018 | 309M |
| FY2019, ended Dec 31, 2019 | 307M |
| FY2020, ended Dec 31, 2020 | 329M |
| FY2021, ended Dec 31, 2021 | 329M |
| FY2022, ended Dec 31, 2022 | 327M |
| FY2023, ended Dec 31, 2023 | 326M |
| FY2024, ended Dec 31, 2024 | 326M |
| FY2025, ended Dec 31, 2025 | 325M |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | 324M |
Buybacks and new shares
By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.
Show tableHide table
| Period | Bought back |
|---|---|
| FY2016, ended Dec 31, 2016 | $255M |
| FY2017, ended Dec 31, 2017 | $407M |
| FY2018, ended Dec 31, 2018 | $354M |
| FY2019, ended Dec 31, 2019 | $360M |
| FY2020, ended Dec 31, 2020 | $153M |
| FY2021, ended Dec 31, 2021 | — |
| FY2022, ended Dec 31, 2022 | $180M |
| FY2023, ended Dec 31, 2023 | $141M |
| FY2024, ended Dec 31, 2024 | — |
| FY2025, ended Dec 31, 2025 | $227M |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | — |
Valuation
At current price- Market Cap
- $68.7B
- P/E
- 14.9×
- Forward P/E
- —. Needs analyst estimates; not available from the current data provider
- Price / Sales
- 9.9×
- Price / Book
- 15.5×
- EV / EBITDA
- 19.4×
Growth
Trailing 12 months- Revenue (TTM)
- $6.94B
- Revenue Growth YoY
- 15.0%
- Revenue CAGR 3Y
- 6.3%
- Revenue CAGR 5Y
- 6.7%
- EPS Growth YoY
- 119%
- Net Income Growth YoY
- 119%
Profitability
Trailing 12 months- Gross Margin
- —
- Operating Margin
- 47.4%
- Net Margin
- 66.5%
- FCF Margin
- 46.4%
- Return on Equity
- 134%
Earnings
Trailing 12 months- Net Income
- $4.62B
- EPS (diluted)
- $14.17
- EBITDA
- $4.97B
- Operating Income
- $3.29B
Balance Sheet
As of Jun 30, 2026- Cash and cash equivalents
- $1.02B
- Total Debt
- $28.7B
- Net Debt
- $27.7B
- Total Assets
- $39.7B
- Total Liabilities
- $33.9B
- Shareholders' Equity
- $4.43B
Cash Flow
Trailing 12 months- Operating Cash Flow
- $4.12B
- Capital Expenditure
- $905M
- Free Cash Flow
- $3.22B
Dividends and risk
Last 12 months- Dividend Yield
- 4.2%
- Dividend / Share
- $8.90
- Beta (5Y)
- 1.30
Every ratio is calculated from the company’s reported figures.